HAIFA, Israel, March 26, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR) announced today that William Prather R.Ph., MD, Sr. VP of Corporate Development, will present at three upcoming financial and scientific events in the U.S. In addition to outlining the progress that Pluristem has made on the development of its PLacental eXpanded (PLX) cell product candidates, Dr. Prather will also speak about the recently announced pre-clinical data on acute radiation syndrome (ARS) and acute myocardial infarction (AMI), the construction of Pluristem's state-of-the-art cell therapy manufacturing facility, as well as the company's strategy of partnering with pharmaceutical companies for the marketing of several of its potential cell therapies.
